PALO ALTO, CA--(Marketwire - December 04, 2008) - CV Therapeutics, Inc. (NASDAQ: CVTX) announced today that, in accordance with Nasdaq marketplace rule 4350, the Company issued new inducement stock options to 35 non-executive officers due to additional hiring, primarily in connection with its commercialization efforts in the United States.
